Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

By sjmartinez • July 5, 2022

Yamamura T, Weinshenker B, Yeaman MR, De Seze J, Patti F, Lobo P, von Büdingen HC, Kou X, Weber K, Greenberg B. Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar. Mult Scler Relat Disord. 2022 Jul 5;66:104025. doi: 10.1016/j.msard.2022.104025. Epub ahead of print. PMID: 36007339.

All clinical trials, All demyelinating disease (CNS), Autoimmune diseases, Devic's syndrome, Neuromyelitis optica spectrum disorder, Patient safety,

Tags: Digestive Diseases, Publications

Oral contraceptive pill-induced esophagitis: a rare cause of pill esophagitis in a Rwandan woman

Bensen GP, Bryan MR, Nishimwe E, Nguyen BS, Chudy-Onwugaje K. Oral contraceptive pill-induced esophagitis: a rare cause of pill esophagitis in a Rwandan woman. Oxf[...]

JPEN Journal Club 92. Adjusting randomized trials

Koretz RL. JPEN Journal Club 92. Adjusting randomized trials. JPEN J Parenter Enteral Nutr. 2025 Mar 31. doi: 10.1002/jpen.2750. Epub ahead of print. PMID: 40162714.

Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial

Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar[...]